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ABSTRACT: The decoration of polyamidoamine (PAMAM)
dendrimers with some functional moieties holds promises for
improving the gene-delivery behavior of the resulting polyplexes.
Herein, we reported the synthesis and the development of non-
viral gene vectors built on an array of PAMAMs, spanning
generation 2 (G2), G4, and G7, specifically tethered with
multivalent neomycin (Neo) or guanidinoneomycin (GNeo).
Following a thorough chemical characterization by means of
NMR and MALDI analyses, the ability of PAMAM−(G)Neo
conjugates to serve as transfectants was investigated. First, we
demonstrated that every PAMAM, whether or not tethered with
Neo (or GNeo), exhibited greater DNA packing ability than the
gold standard transfectant 25 kDa bPEI. Measurements of the
colloidal properties showed that PAMAMs, when mixed with
plasmid DNA (pDNA) as a function of the nitrogen-to-phosphate ratio (N/P), allowed preparing complexes of ≈150−300 nm
in diameter with a positive surface charge of ≈+20−35 mV, strictly dependent on the PAMAM generation. The conjugation
with Neo affected the DNA release behavior from PAMAM-based polyplexes and their ultimate transfection efficiency. When
low generation PAMAM G2 was tethered with Neo, we obtained the most efficient transfectants, with remarkable antibacterial
activity against Gram negative bacteria. It is worth noting that pDNA/PAMAM−(G)Neo nanoassemblies, which were tested at
the optimal N/P, invariably showed better transfection efficiency than 25 kDa bPEI, along with low cytotoxicity in both HeLa
and COS-7 cells. Altogether, these results underline the potential of such PAMAM−(G)Neo dendrimers as promising vehicles
for efficient gene delivery into cells.
■ INTRODUCTION
Dendrimers are a class of synthetic and well-structured
polymers with excellent monodispersity and symmetrical
three-dimensional (3D) branched architecture.1−3 Because of
such structural perfection, along with being highly branched,
the presence of multiple peripheral end groups and internal
cavities, and the relative ease of synthesis (overall for low
generations), dendrimers have attracted much interest for a
number of applications.4,5 For instance, they have been used as
antibacterial agents6,7 and antimicrobial surface coatings,8
nanocarriers for smart drug delivery,9−13 diagnostic agents,14,15
and theranostics overall.16 Above all, dendrimers have attracted
great attention as a valid alternative to immunogenic viral
vectors for the delivery of nucleic acids (NAs).17 Polyamido-
amine (PAMAM) dendrimers have been probably the most
explored, because of some unique features, such as (1) their
inherent ability to condense polyanionic NAs into the so-called
dendriplexes, (2) the efficient cellular uptake of PAMAM
dendriplexes on different cell lines and their localization into
endo-lysosomes, (3) the presence of tertiary amines in the
backbone responsible for the “proton sponge” effect favoring
endosomal escape, (4) the presence of outer primary amino
groups, cationic at physiological pH, and (5) their non-
immunogenicity.18 Although not very effective for siRNA
delivery, structurally flexible PAMAMs have been used for gene
silencing purposes as well.19,20 However, some issues have
been hampering their applications to a greater extent. Indeed,
as gene-delivery systems, PAMAM dendrimers have proven to
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suffer from the transfection efficiency and cytotoxicity paradox.
High generation dendrimers are much more efficient trans-
fectants, though they display severe cytotoxicity. Besides, the
synthesis of high generation PAMAM dendrimers is unfortu-
nately time-consuming and expensive, which largely limit their
biomedical applications.21 On the other hand, low generation
dendrimers are notoriously less toxic but less effective because
of the poor plasmid DNA (pDNA) complexation/decom-
plexation ability. In order to make dedrimeric PAMAMs ideal
gene-delivery vectors, it has been reported the functionaliza-
tion of high generation PAMAMs with different ligands such as
lipids, fluorous compounds,22,23 amino acids, polysaccharides,
proteins and peptides, other polymers, and some cationic
moieties,17 while low generation PAMAMs have been
nanoclustered through covalent and non-covalent bond-
ing.20,24−26 In this contest, we have recently designed a new
class of multifunctional PAMAM−aminoglycoside (AG)
conjugates27 obtained by grafting three different AGs, neamine
(Nea, bearing three amino groups), paromomycin (Paro,
bearing five amino groups), and neomycin B (Neo, bearing six
amino groups) antibiotics on the outer primary amino groups
of PAMAM generation 4 (PAMAM G4). Such multifunctional
PAMAM G4−AGs displayed high gene-delivery efficiency
along with negligible cytotoxicity, the PAMAM G4−Neo
derivative being the most performing at low N/P.
Herein, we report a step further in the structure−function
relationship analysis of such dendrimers, that is, the evaluation
of the effects of different PAMAM generations, namely G2, G4,
and G7, on the efficiency and cytotoxicity of PAMAM−Neo
conjugates (PAMAM G2−, G4−, G7−Neo). Starting from
PAMAM G2, G4, and G7, we synthetized three polymeric
conjugates with Neo using isothiocyanate/amine click
chemistry (Figure 1). Moreover, along with PAMAM−Neo
conjugates, we have synthetized also PAMAM G4−guanidi-
noneomycin (PAMAM G4−GNeo) in order to study the
influence of guanidinylation on the gene transfection efficiency
of these dendrimers. The antibacterial effectiveness of the
resulting polymers and polyplexes was evaluated as well.
■ RESULTS AND DISCUSSION
Since their first use in 1993,28 PAMAM dendrimers have been
extensively investigated as non-viral gene-delivery vectors.
Being dendrimers, PAMAMs possess a well-defined structure,
characterized by many functional end groups, responsible for
high solubility (especially at low generations) and reactivity
and inner cavities serving as binding sites for drugs. In spite of
their fairly good transfection efficiency (especially at high
generations), the widespread use of PAMAMs as delivery
agents is limited because of their inherent toxicity and high
cost. On the other hand, the chemical reactivity of primary
amino end groups of PAMAMs allows for and easy
functionalization with specific moieties to give rise to more
effective gene vectors.
In this context, we propose the synthesis of an array of
PAMAM dendrimers, namely, PAMAM G2, G4, and G7,
decorated with the (guanidino)neomycin moiety (hereinafter
referred to as (G)Neo). After a thorough chemical character-
ization to calculate the grafting yield, we evaluated and
compared the performances of PAMAM−(G)Neo dendrimers
with those of the parent pristine PAMAMs in transfection, in
order to shed light on the role of the dendrimer generation on
grafting and thus on their ultimate transfection efficiency in
Figure 1. Schematic representation of PAMAM G2−, G4−, G7−Neo, and PAMAM G4−GNeo conjugates.
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two cell lines, namely, HeLa and COS-7 cells. The
antimicrobial activity of the whole array of PAMAMs and
PAMAM derivatives was evaluated as well.
Synthesis and Characterization of PAMAM G2−, G4−,
G7−Neo and PAMAM G4−GNeo Conjugates. AGs are a
class of polyaminosugar antibiotics that have been widely used
as chemotherapeutic agents in the treatment of bacterial
infections and, more recently, as antifungal agents.29−31
Because of their cationic-bearing moieties, AGs have already
been used to build cationic amphiphils32−34 and polymers35−37
for gene delivery. In this context, we have previously developed
dendrimeric PAMAM G4−AG conjugates and studied their
effectiveness as gene-delivery systems in three different cell
lines.27 Considering the high performances obtained with such
vectors, especially those of PAMAM G4 tethered with Neo and
Paro, we decided to investigate more in depth the influence of
the PAMAM generation on the ultimate transfection efficiency
of the resulting dendriplexes. Moreover, because it has been
shown that the conversion of the primary amines of AGs into
guanidino groups increases dramatically the ability of
Scheme 1. Synthesis of PAMAM−(G)Neo Conjugates 1−4
Table 1. Degree of Grafting Calculated by 1H NMR Integrations and MALDI Mass Analysis
aThe values are calculated subtracting the number of the hydrogens belonging to the PAMAM dendrimers to the hydrogens resonating between 3.1
and 2.7 ppm. bThe degree of grafting was determined dividing the calculated hydrogens belonging to the linker for 6 (the number of hydrogens of
the linker resonating between 3.1 and 2.7 ppm for the monomeric AG) and rounded to the nearest unit. cIt was not possible to detect the MW of
the conjugate, but we detected the peak corresponding the MW of the 40 Neo-linker unit. dThe MW was not detected probably because the
dendrimer does not vaporize.
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guanidinoAGs to deliver high molecular weight cargos into
cells,38−41 we decided to explore the effect of guanidinylation
synthesizing a PAMAM G4−GNeo derivative. Likewise, we
exploited the chemistry to anchor AGs and GNeo to the
dendrimers, namely, click reaction between isothiocyanate-
functionalized AGs with the primary amino groups of the
PAMAM dendrimers, while we slightly modified the linker in
order to obtain the final conjugates in better yields and in a
simpler way. In detail, starting from commercially available
Neo 5, we have synthetized propargylic derivatives 6 and 7
following reported procedures (Scheme 1).42
Click reaction with isothiocyanate linker 8 (see Scheme S1
in the Supporting Information for the synthesis) led to the
formation of intermediates 9 and 10, respectively, in good
yields, which were next coupled with PAMAM G2, G4, and G7
following the same conditions (DMSO, 40 °C, 12 h). After
Boc-deprotection with trifluoroacetyl (TFA), dialysis in water,
and freeze-drying, final PAMAM G2−Neo 1, PAMAM G4−
Neo 2, PAMAM G7−Neo 3, and PAMAM G4−GNeo 4 were
obtained as fluffy solids.
According to our previous studies,27,38 the degree of grafting
was first established by 1H NMR analysis. Integration of the
characteristic signals belonging to the Neo anomeric protons
(three singlets resonating between 6.2 and 5.2 ppm), the
protons belonging to the triazole ring (which resonates around
8.0 ppm), was compared to the integration of the broad
multiplet resonating between 3.1 and 2.7 ppm which
correspond to (1) the methylene protons in the α position
to the carbonyl group of PAMAM dendrimers (56 protons for
PAMAM G2, 248 protons for PAMAM G4, and 2040 protons
for PAMAM G7), (2) the two methylene groups in the α
position to the sulfur atom and (3) the methylene in the α
position to the carbonyl group, both belonging to the linker.
The relative integrations of these signals revealed that we
grafted 13 Neo to PAMAM G2, 40 Neo and 15 GNeo to
PAMAM G4, and 307 Neo to PAMAM G7 (Table 1). The
lower degree of grafting obtained with GNeo isothiocyanate 10
as compared to the corresponding Neo derivative 9 could be
ascribed to the different steric hindrance. Besides PAMAM
G7−Neo 3, the degrees of grafting of 1, 2, and 4 were also
supported by MALDI mass analysis, through which the average
molecular mass of the dendrimer derivatives was evaluated and
compared to those calculated (Table 1).
Evaluation of DNA-Binding Ability and Release
Behavior of PAMAM and PAMAM−(G)Neo Conjugates.
The delivery of naked pDNA into cells is not efficient because
of the enzymatic degradation (by DNases) of NAs and the
charge repulsion with the plasma membrane. Thereby, safe and
Figure 2. DNA complexation ability (left panels) and decomplexation ability (right panels) of PAMAM G2, G4, and G7 (black line) and their
respective conjugates (red line or blue dotted line): (A) G2; (B) G4; (C) G7. Results are expressed as mean ± SD (n = 3).
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efficient introduction of DNA/RNA into cells by means of
synthetic vectors that do shield and protect the genetic cargo is
of paramount importance for successful gene delivery. As for
other polycations, such as polylysine and polyethylenimine
(PEI), PAMAM dendrimers have been shown to self-assemble
with NAs through electrostatic interactions to form dendri-
plexes.43 PAMAM dendrimers contains in their backbone both
tertiary amines at branching points, as well as protonated
primary amino groups at the termini, the latter being
responsible for the binding of the pDNA phosphates. Besides,
it has been found that Neo-tethering to dendrimers did
enhance the ability of such polymers to pack the DNA.27
In this study, PAMAMs at different generations, that is, G2,
G4, and G7, and their respective (G)Neo conjugates were used
to complex and compact pDNA into polyplexes. We thus first
evaluated by fluorophore-exclusion assay the ability of these
three different arrays of gene-delivery vectors to bind and
condense pDNA as a function of the nitrogen-to-phosphate
ratio (N/P) (Figure 2, left panels). By plotting the
fluorescence intensity versus N/P, all the dendrimers tested
displayed typical quasi-sigmoidal curves (PAMAM G2 and
G2−Neo: Figure 2A; PAMAM G4, G4−Neo and G4−GNeo:
Figure 2B; and PAMAM G7 and G7−Neo: Figure 2C).
Overall, PAMAM derivatives invariably showed higher
affinity for DNA than PEI, whose maximum pDNA complex-
ation ability (i.e., when DNA is no longer accessible to the
SYBR Green I because totally secluded in complexes) was
found at N/P ≥ 3.44,45 Of note, PAMAM G2 did displace
slightly less SYBR Green I, showing a residual fluorescence
signal of ≈10% even at high N/Ps (Figure 2A). This behavior
probably relies on the less tight binding of DNA owing to the
little surface charge density of this low generation den-
drimer.46−48 Interestingly, the presence of Neo increased the
affinity of PAMAM G2 for pDNA, this AG being a well-known
Figure 3. Physico-chemical characterization of pDNA/PAMAMs and pDNA/PAMAM−AG complexes. Mean hydrodynamic diameter (DH; black
circle (star) and solid (dashed) line) and overall surface charge (ζP; red square (star) and dotted (dashed) line), measured by DLS and laser
doppler microelectrophoresis, of: (A) pDNA/PAMAM G2 (left panel) and pDNA/PAMAM G2−Neo (right panel) complexes; (B) pDNA/
PAMAM G4 (left panel) and pDNA/PAMAM G4−(G)Neo (right panel) complexes; and (C) pDNA/PAMAM G7 (left panel) and pDNA/
PAMAM G7−Neo (right panel) complexes. Results are expressed as mean ± SD (n = 3).
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NAs binder.49 Indeed, PAMAM G2−Neo was able to
completely condense pDNA at N/P ≥ 1.5.
Besides, unconjugated PAMAM G4 and G7 displayed
similar behaviors because the greatest DNA complexation
efficiency was at N/P 1. When tethering such PAMAMs with
Neo or GNeo, a displacement of the complexation curve at
high N/Ps was observed (maximum complexation ability at N/
P 1.5 for PAMAM G4−Neo and N/P 2 for PAMAM G4−
GNeo and G7−Neo derivatives).
Parent PAMAMs showed different release behaviors with
respect to their respective Neo conjugates (Figure 2, right
panels). Indeed, in the presence of heparin, PAMAM G2-, G4-,
Figure 4. Cytotoxicity and transfection efficiency (EGFP expression and Luc activity) of PAMAM and PAMAM−(G)Neo-based complexes in
HeLa cells, prepared by mixing pGL3 (or pEGFP) with PAMAMs at different N/Ps. Cytotoxicity of free polymers (without DNA) was evaluated as
well. (A) PAMAM G2 and PAMAM G2−Neo; (B) PAMAM G4, PAMAM G4−Neo and PAMAM G4−GNeo; and (C) PAMAM G7 and
PAMAM G7−Neo. pGL3/25 kDa bPEI complexes at N/P 10 were used as the internal reference of transfection. Results are expressed as mean ±
SD (n ≥ 4) (*p < 0.05 vs unconjugated PAMAM; §p < 0.05 vs PAMAM G4−GNeo; #p < 0.05 vs bPEI). Scale bar in fluorescent micrographs: 10
μm.
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and G7-based nanoassemblies at 1 ≤ N/P ≤ 5 were prone to
decomplexation, and ≈90% of total pDNA was released out.
Under the same decomplexation conditions, PAMAM G2−
Neo and G4−Neo-based dendriplexes released less pDNA, as a
result of the greater stability of such assemblies. Such stability
can be a critical issue for gene-delivery vectors, especially in
anionic environments such as those that transfectants have to
face up to in vitro and in vivo (e.g., the presence of serum,
plasma glycoproteins and glycolipids). On the other hand, the
poorer DNA release behavior displayed by PAMAM G4−
GNeo and PAMAM G7−Neo means that their respective
polyplexes are more stable, and such stability may have a
detrimental effect on intracellular DNA release and thus on
transfection. In light of this, in order to develop gene delivery
as effective as possible, we need to find a balance between
stability of complexes and ease of DNA release.50
Physico-chemical Characterization of PAMAM− and
PAMAM−(G)Neo-Based Polyplexes. As PAMAM G2, G4,
and G7 dendrimers display a well-defined three-dimensional
structure and chemistry, such features allow preparing
complexes with a consistent structure, size, and surface
charge.48 Therefore, we investigated by dynamic light
scattering (DLS) and electrophoretic light scattering the
hydrodynamic diameter (DH) and the zeta potential (ζP) of
every dendriplex in order to find a possible correlation between
the physico-chemical properties of PAMAM and PAMAM−
Neo-based complexes and the transfection behaviors in vitro.
In fact, it is well accepted that the size and surface charge are
among the key factors affecting the transfection performances
of any gene-delivery vector, at least in vitro.44,45
PAMAM G2, G4, and G7 dendrimers in association with
pDNA did form nanometric assemblies at N/P ≥ 2 (i.e., at the
same N/P in which the DNA is totally buried within
dendriplexes), while the DH profile of every PAMAM−Neo
derivative was fairly constant at N/P ≥ 5 (Figure 3). The ζP
curves of low generation PAMAMs and PAMAM−Neo
derivatives as a function of N/P fitted well with an exponential
decay equation model, while the best curve fit for PAMAM G7
and G7−Neo was the linear least-squares line with slope 0, so
that we found only minor variations in the overall dimensions
of dendriplexes as the N/P was increased.
In more detail, complexes of PAMAM G2 and G7 and their
corresponding −Neo conjugates, prepared at N/P ≥ 2, showed
similar dimensions, ranging over a narrow distribution of
≈100−170 nm (Figure 3A,C) (p > 0.05 for every series), along
with highly positive ζP, in good agreement with previously
published data.48 Among them, pDNA/PAMAM G7 com-
plexes displayed the highest ζP of ≈+35 mV, while PAMAM
G2-based dendriplexes exhibited an overall surface charge of
+20−25 mV. Such results substantiate the evidence that
surface charge is related to dendrimer generation, with
PAMAM G2 and G7 showing different ζP behaviors,
irrespective of the N/P.
On the other hand, PAMAM G4-based complexes (at N/P
≥ 2) displayed the largest DH, ranging from 200 to 450 nm
(Figure 3B), and the lowest ζP of ≈+10 mV, in agreement with
previously published data.27,51 The conjugation with Neo,
whether or not guanidinylated, gave rise to the formation of
smaller complexes with DH < 200 nm (Figure 3B) and higher
ζP of ≈+25 mV (at N/P ≥ 5). It is also apparent that no stable
and fully condensed dendriplexes were found for PAMAM G2
and G4 series at N/P < 2, as highlighted by high DH values and
the overall negative surface charge (Figure 3A,B). This was
probably because in such conditions residual unshielded DNA
was still present.
Taken together, these results led to the conclusion that all
PAMAMs effectively condense pDNA into nanoassemblies
with positive surface charge, although to a different extent.
This is a compulsory requirement for gene-delivery vectors.
In Vitro Transfection of pDNA/PAMAMs and pDNA/
PAMAMs−(G)Neo Conjugates. Transfection efficiency
mediated by PAMAM dendrimers has been shown to be
dependent on the dendrimer generation. In fact, the higher the
generation, the greater the efficiency.48,52
In two cell lines, namely, HeLa and COS-7 cells,
dendriplexes obtained through the mixing of PAMAM G2
(−Neo), G4 (−Neo), and G7 (−Neo) with pDNA at N/P ≥ 5
exhibited transfection efficiencies (in terms of Luc activity)
similar or even greater than the gold standard 25 kDa bPEI. Of
note, pristine PAMAMs displayed different, generation-specific
transfection behaviors. As clearly shown in Figure 4, pDNA/
PAMAM G4 showed the lowest transfection efficiency,
regardless of the N/P tested. Such outcome is not surprising
if considering the lower ζP displayed by PAMAM G4-based
dendriplexes with respect to that of the other PAMAMs. On
the other hand, pDNA/PAMAM G7 displayed the highest
transfection efficiency at almost all N/Ps tested, with the
greatest transgene expression at N/P 75 (Figure 4C, right
panel) and a very low cytotoxicity (Figure 4C, left panel).
Besides, the transfection efficiency of pDNA/PAMAM G2
dendriplexes showed a bell-shape trend, with the maximum
centered at N/P 45 (Figure 4A, right panel). Our findings
show that high generation dendrimers (PAMAM G7) were
more effective in transfecting cells than the less branched
counterparts (PAMAM G2 and G4). Similar results were
reported by Kukowska-Latallo as well.52 Although to a different
extent, such trends were also found transfecting COS-7 cells,
both in terms of cytotoxicity (Figure S5, left panels) and Luc
activity (Figure S5, right panels).
We have recently shown that the conjugation of PAMAM
G4 with AGs, such as Neo, Paro, and neamine, dramatically
enhanced the transfection behavior.27 In the present study, we
made another step forward in putting the puzzle together
through the investigation of the possible effects of grafting
different generations of PAMAM dendrimers with the AG unit
Neo.
Interestingly, PAMAM G2−Neo dendriplexes at any N/P
tested displayed a ≈10-fold increase in the Luc expression than
the pristine PAMAM G2 one in both HeLa (Figure 4A, right
panel) and COS-7 cells (Figure S5A, right panel). Instead,
PAMAM G7−Neo displayed an opposite behavior. In fact,
from Figure 4C (and Figure S5C), it is apparent that pDNA/
PAMAM G7−Neo dendriplexes induced lower luciferase
expression in HeLa cells (and COS-7 as well) than pDNA/
PAMAM G7 complexes, especially for high N/Ps. It is worthy
of note that the physico-chemical features of complexes
prepared with PAMAM G2 and G7 (and the corresponding
−AG conjugates) were quite different (PAMAM G2(−Neo) at
N/P 5−75: ζP ≈ +25 mV versus PAMAM G7(−Neo) at N/P
5−75: ζP ≈ +35 mV), which means that the differences found
in transfection may rely on the PAMAM generation under-
pinning the specific features of pDNA/PAMAM assemblies.
Yet, the poorer DNA release behavior displayed by PAMAM
G7−Neo limited in some way their transfection efficiency.
Similar to PAMAM G2 series, pDNA/PAMAM G4−Neo
dendriplexes were much more efficient in transfecting HeLa
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(Figure 4B) and COS-7 cells (Figure S5B) than complexes
prepared with parent PAMAM G4. In particular, PAMAM
G4−Neo was more effective at N/P 30 in both cell lines.
On the other hand, a similar trend was observed when GNeo
was tethered to PAMAM G4. As reported in Figure 4B, the
transfection efficiency of pDNA/PAMAM G4−GNeo com-
plexes was higher than that of PAMAM G4 complexes
prepared at N/P > 5, and the cytotoxicity they showed was
low-to-negligible.
As expected, also the transfection profiles of such
dendriplexes were strongly dependent on the N/P and the
cell line used to carry out transfections; when used to transfect
HeLa and COS-7 cells, pDNA/PAMAM G4−GNeo com-
plexes were indeed more effective at N/P 30 and N/P 75,
respectively (Figure 4B, right panel, and S5B, right panel).
Besides, pDNA/PAMAM G4−GNeo complexes were less
efficient than the −Neo counterparts. Such findings mirrored
the results reported by Lehn’s group.53 The reasons for such
unfavorable effect can be ascribed to the poorer DNA release
ability shown by PAMAM G4−GNeo (Figure 3). It is widely
accepted that the grafting of guanidino groups to macro-
molecules favors their cellular uptake.38,39,41 However, after
polyplex uptake, the DNA decomplexation has to occur in a
way as efficient as possible in order to enable the release of the
transgene and thus its transcription. Our experimental
evidence suggests that the presence of guanidinium moieties,
in lieu of the primary amines, is likely to strengthen the
interaction with the DNA, thus increasing excessively the
stability of complexes so that cells are hardly able to
disassemble them intracellularly. Besides, we may speculate
that the strong basicity of the guanidino group may also affect
the buffering capacity of the PAMAM dendrimers, which is
one of the reasons of the high transfection activities of several
cationic vectors such as PEI.54
In order to actually visualize transfection, EGFP-encoding
complexes were delivered to HeLa cells at optimal N/P
(PAMAM G2 and G2−Neo: N/P 75; PAMAM G4 and G4−
Neo: N/P 30; and PAMAM G7 and G7−Neo: N/P 75), as
reported in Figure 4.
It is worth noting that every PAMAM−(G)Neo dendrimer,
when tested at the optimum N/P, invariably exhibited greater
transfection efficiency than the gold standard 25 kDa bPEI in
both HeLa and COS-7 cells.
On the other hand, although a high cationic charge density
allows polymers to associate with DNA and to give rise to
nanoassemblies amenable to cellular internalization, the latter
process is also known to adversely impact cell viability. As the
overall cytotoxicity of a given non-viral gene-delivery vector
depends on its inherent toxicity, which relies on the chemical
structure and composition, and on the physico-chemical
properties of the resulting polyplexes (i.e., their size (DH)
and surface charge (ζP)), we have challenged HeLa cells with
polyplexes at different N/Ps and free polymer solutions
(prepared at the same polymer concentration used to complex
pDNA at different N/Ps, but without DNA addition). For
every N/P tested, the cytotoxicity of polyplexes basically
mirrored that of free polymers (Figures 4 and S5; p > 0.05 for
all the conditions), probably because at N/P ≥ 5, most of the
Figure 5. Antibacterial activity of complexes and (DNA-free) polymer solutions of PAMAMs and their respective (G)Neo-conjugates against E.
coli. (A) PAMAM G2 and PAMAM G2−Neo; (B) PAMAM G4 and PAMAM G4−(G)−Neo; (C) PAMAM G7 and PAMAM G7−Neo (right
panels). Results are expressed as mean ± SD (n = 3) (*p < 0.05 complexes vs polymer solutions).
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polymer is not engaged in interactions with pDNA (maximal
complexation ability at N/P ≤ 2 for all the PAMAMs). Most
importantly, these results highlight the inherently low
cytotoxicity of PAMAM−(G)Neo conjugates.
Antibacterial Activity of pDNA/PAMAMs and pDNA/
PAMAMs−(G)Neo Conjugates. PAMAM dendrimers have
been extensively investigated for biomedical applications,
especially for delivery of drugs, including antimicrobial drugs,
to mammalian cells. Although PAMAM and other dendrimers
have been widely used as carriers or scaffolds for the covalent
tethering of antimicrobial agents, such as antibiotics,55,56 the
antimicrobial effectiveness of PAMAM dendrimers themselves
has only been recently discovered.57 In this light, modification
of the PAMAM’s amino groups with Neo, a well-known and
widely used antibiotic active against Gram-negative bacteria,58
may enhance the antibacterial performance of such den-
drimers. We thus hypothesized that PAMAM G2, G4, and G7,
whether or not conjugated with Neo, might have antibacterial
activity. We thus tested the potential antimicrobial activity
against Gram negative Escherichia coli (E. coli) bacteria of
PAMAM conjugated 1−4, used as aqueous (polymer)
solutions and in the form of suspensions of pDNA/
PAMAM−(G)Neo complexes and compared their perform-
ances to those of unconjugated dendrimers.
As clearly shown in Figure 5, unconjugated PAMAMs were
ineffective against E. coli. Interestingly, the conjugation with
Neo dramatically increased the antibacterial activities of
dendrimers (Figure 5), especially when low generation
PAMAM was used. Among the PAMAM−Neo derivatives,
PAMAM G2−Neo was the most effective antibacterial
compound, and its effects were concentration-dependent
(Figure 5A, left panel).
The tethering of PAMAM G4 with the antibiotic Neo
induced a mild increase in antibacterial activity, whereas the
guanidylation of the AG’s amino group totally blunted its
activity (Figure 5B). Based on these findings, we can speculate
that the antimicrobial effect of PAMAM conjugates specifically
rely on the grafting of the pristine antibiotic moiety on the
dendrimer.
Altogether, these results disclose PAMAM G2−Neo as a
promising gene-delivery transfectant with good antibacterial
properties.
■ CONCLUSIONS
Herein, we have synthesized and characterized a series of four
different PAMAM−(G)Neo conjugates, namely, PAMAM
G2−Neo, PAMAM G4−Neo, PAMAM G4−GNeo, and
PAMAM G7−Neo. We evaluated their ability to condense
DNA and to release it in the presence of a decomplexation
agent. Moreover, their cytotoxicity and ability to transfect two
cell lines were evaluated as well. Besides PAMAM G7−Neo, all
the other conjugates showed greater transfection efficiencies as
compared to their corresponding undecorated PAMAM
dendrimers. The PAMAM G4−GNeo derivative was much
less efficient than the corresponding Neo derivative although
GNeo (and in general guanidinylation) is known to promote
efficient cellular uptake. Of note, PAMAM G2−Neo was the
most effective transfectant because very efficient (and much
more efficient than gold standard transfectant 25 kDa bPEI) at
any N/P. Notably, small PAMAM G2−Neo were able to
completely condense pDNA, which was not the case for the
undecorated PAMAM G2, and, at high N/P (N/P ≥ 45),
displayed low cytotoxicity and was more efficient in trans-
fecting HeLa cells than PAMAM G4−Neo.
Benefiting from the grafting of AGs, PAMAM G2−Neo
exhibited very good antibacterial activity against E. coli. These
results are very intriguing because low generation dendrimers
are cheaper, safer, and easier to functionalize as compared to
the higher generation counterparts. Overall, this study
highlights the beneficial effect on transfection of Neo-grafting
on low- (G2) to medium- (G4) generation PAMAM
dendrimers. Because of high transfection efficiency, low
cytotoxicity, and low costs, PAMAM G2−Neo is a very
promising gene-delivery vehicle.
■ MATERIALS AND METHODS
Materials. Neo sulfate, PAMAM G2, G4, and G7
dendrimers, and 25 kDa bPEI were from Sigma-Aldrich
(Milan, Italy). Spectra/Por dialysis bags (MWCO = 1 and 8
kDa) were from Spectrum Laboratories (Compton, CA, USA).
HeLa (human cervix carcinoma, CCL-2) and COS-7
(monkey kidney tissue-derived fibroblast-like, CRL-1651) cell
lines were purchased from the American Type Culture
Collection (ATCC, Manassas, VA, USA). AlamarBlue Cell
Viability Assay was from Life Technologies Italia (Monza,
Italy), while the BCA Protein Assay Kit was from Thermo
Fisher (Monza, Italy). pDNA encoding the modified firefly
luciferase (pGL3-Control Vector, 5.2 kbp) and Luciferase
Assay System were obtained from Promega (Milan, Italy),
while pDNA encoding the enhanced green fluorescent protein
(pEGFP-N1, 4733 bp) was purchased from Clontech
Laboratories (Mountain View, CA).
E. coli JM109, (Gram negative bacterial strain, biosafety
level: 1) were purchased from Leibniz Institute DSMZ-
German Collection of Microorganisms and Cell Cultures
(Braunschweig, Germany).
All the other chemicals were from Sigma-Aldrich, if not
differently specified.
Synthesis of PAMAM−AG Conjugates 1−4: General
Procedure. The organic solvent of commercial 10% (w/w)
methanolic solution of PAMAM of different generations was
evaporated in vacuo and co-evaporated twice with dichloro-
methane. Neat PAMAM was dissolved in DMSO and a
solution of the AG−isothiocyanate linker (1.2 equiv per NH2
group) in a minimal volume of DMSO was added. The
solution was stirred at 60 °C for 24 h. The solution was
dialyzed against MeOH (8 h, the solvent reservoir was
renewed three times, MWCO = 1 and 8 kDa). The solution
was evaporated under reduced pressure to give N-Boc-
protected PAMAM−AG derivatives. The resulting conjugates
were dissolved in TFA and stirred for 30 min at room
temperature (rt). The excess of TFA was evaporated under
reduced pressure, the crude dissolved in demineralized water
(dH2O), and the solution dialyzed overnight (ON) against
dH2O (MWCO = 1 kDa). Freeze-drying of the resulting dH2O
solution lead to recover fluffy, white solids. Complete N-Boc
deprotection occurred in all cases as evidenced by the NMR
spectra.
Preparation of Dendrimer Solutions. PAMAM G2, G4,
and G7 were diluted in dH2O to a final concentration of 4.48,
5.0, and 5.0 mg/mL, respectively, corresponding invariably to
final nitrogen concentration ([N]) of 22 mM. PAMAM G2−
Neo, G4−Neo, and G4−GNeo derivatives were diluted in
dH2O to a final concentration of 4.05, 4.12, and 4.57 mg/mL,
respectively, corresponding invariably to a final nitrogen
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concentration ([N]) of 13 mM. PAMAM G7−Neo was
diluted in dH2O to a final concentration of 2.07 mg/mL,
corresponding to final [N] of 6.5 mM, while 25 kDa bPEI was
diluted in 10 mM HEPES to a final concentration of 0.86 mg/
mL and a [N] = 20 mM, considering that there is one nitrogen
per repeat PEI unit (−NHCH2CH2−, MW = 43 Da).59
Dendrimers and bPEI were stored at 4 °C until use.
Preparation of Polyplexes and Evaluation of DNA
Binding and Release Ability. The DNA binding and release
ability of every PAMAM and PAMAM−Neo conjugates were
monitored by fluorophore-displacement assay. First, pDNA
was amplified, isolated, purified, and diluted in 0.1× TE buffer
(1 mM Tris, pH 8; 0.1 mM EDTA) as previously described.60
Dendriplexes were invariably prepared by mixing 0.25 μg of
pDNA in 1.0 μL of 200× SYBR Green I (λex = 497 nm, λem =
520 nm) with 11.8 μL of PAMAMs and PAMAMs−Neo
solutions at different concentrations, yielding a final DNA
concentration of 20 ng/μL and different N/Ps. N/P is defined
as the moles of amines (N, cationic moiety) of the dendrimer
and Neo, when applicable, which are used to complex the
phosphate groups (P, anionic moiety) of a given quantity of
DNA. Afterward, polyplexes were incubated for 30 min at rt,
then diluted 1:16 (v/v) in 10 mM HEPES or 200 μg/mL of 10
mM HEPES-containing heparin. Fluorescence measurements
(n = 3 per condition) were performed with a GENios Plus
Reader (Tecan, Segrate, Italy) in 384-well black plates. Data
are expressed as relative fluorescence normalized to the
fluorescence of uncomplexed pDNA.
Measurement of the Size (DH) and Zeta-Potential (ζP)
of Complexes. For physico-chemical characterization, com-
plexes were prepared as described above. Briefly, 1 μg of
pDNA was mixed with PAMAMs and PAMAMs−Neo
solutions to yield different N/Ps (i.e., 5, 15, 30, 45, 60, and
75), incubated for 30 min at rt then diluted 1:15 in 10 mM
HEPES. The hydrodynamic diameter (DH) and surface charge
(ζP) of dendriplexes were measured at 37 °C by DLS and laser
Doppler micro-electrophoresis using a Malvern Zetasizer Nano
instrument (Malvern, Italy), fitted with a 5 mV HeNe laser (λ
= 633 nm) and a scattering angle of 173°.
In Vitro Cells Transfection Experiments. Cell Cultures.
Mycoplasma-free HeLa and COS-7 cells were cultured in
Dulbecco’s modified Eagle’s medium containing 1 mM sodium
pyruvate, 10 mM HEPES buffer, 100 U/mL penicillin, 0.1 mg/
mL streptomycin, 2 mM glutamine, and supplemented with
10% (v/v) fetal bovine serum (i.e., culture medium) in a
humidified atmosphere under a constant supply of 5% CO2
and at 37 °C.
In Vitro Cell Transfection. Cells were seeded onto 96-well
plates at a density of 2 × 104 cells/cm2 and maintained in
standard culture conditions for 24 h. Next, 160 ng/well of
pGL3 were complexed in 10 mM HEPES with PAMAMs and
PAMAMs−Neo solutions to yield different N/Ps, as described
herein above, and cells were incubated with complexes in 100
μL/well of culture medium under standard culture conditions
for further 48 h. Cells transfected with 25 kDa bPEI/DNA
complexes prepared at N/P 10 were used as internal
refs.34,44,45
Following 48 h transfection, cytotoxicity was evaluated by
means of AlamarBlue assay according to manufacturer’s
instructions. Briefly, medium was removed and each well was
loaded with 100 μL of culture medium containing 1× resazurin
dye. Cells were next incubated in standard culture conditions
for 2 h, and then the fluorescence of the medium was read with
a GENios Plus reader (λex = 540 nm; λem = 595 nm). Viability
of untransfected cells (CTRL) was assigned to 100% and
cytotoxicity was calculated as follows
Cytotoxicity % 100% viability %[ ] = − [ ]
Cytotoxicity of free polymers (PAMAM solutions tested at
the same concentrations used to complex pDNA) was
evaluated as well.
Transfection efficiency was evaluated measuring the
luciferase activity by means of the Luciferase Assay System,
according to manufacturer’s instructions. Briefly, cells were
washed with phosphate buffered saline (PBS) and lysed with
110 μL/well of the Cell Culture Lysis Reagent (Promega,
Italy). Following a freeze−thawing cycle, 20 μL of cell lysates
were added to 50 μL of the Luciferase Assay Reagent, and
luminescence was measured by means of a GENios Plus
reader. The luminescence signal (expressed as relative light
units, RLU) of each sample was normalized to its protein
content determined by BCA assay. Transfection efficiencies
were thus expressed as RLU/mg of proteins.
To qualitatively assess transfection, HeLa cells were plated at
the same cell density as reported herein above onto glass
coverslips (Ø = 15 mm), placed into separate wells of 24-well
culture plates, and maintained in standard culture conditions
for 24 h. Afterward, 160 ng/cm2 of pEGFP was complexed
with PAMAM− and PAMAM−(G)Neo solutions to give the
most effective N/Ps as for pGL3, and cells were incubated for
additional 48 h in standard culture conditions. At the end of
transfection, cells were rinsed with PBS, fixed in 4% (w/v)
paraformaldehyde solution for 20 min, and permeabilized for
30 min at RT with 0.01% (w/v) Triton X, 3% (w/v) BSA in
PBS. Next, cell nuclei were counterstained with Hoechst 33342
at a 1:1000 dilution (v/v) in PBS plus 3% (w/v) BSA.
Coverslips were subsequently mounted on glass slides and
digital images were taken with a Zeiss Axioplan fluorescent
microscope at 40× magnification.
Antibacterial Tests. The antibacterial effectiveness of
PAMAM G2, G4, G7, and their corresponding (G)Neo
derivatives were tested against Gram negative E. coli JM109
bacterial strain, as previously described.34 Briefly, bacteria were
cultured in 5 mL of Luria-Bertani (LB) broth at 37 °C under
shaking at 130 rpm, ON, until reaching an optical density at λ
= 600 nm (OD600nm) ≈ 1, corresponding to ≈109 bacteria/mL.
Bacterial suspensions were next diluted to a final concentration
of ≈106 bacteria/mL used as the test inoculum for the
experiments. For antibacterial tests, 50 μL/well of bacterial
suspension was inoculated into separate wells of 96-well plates
(corresponding to a bacterial density of 1.5 × 105 bacteria/
cm2), then 50 μL/well of LB containing pDNA/PAMAMs
complexes prepared at varying N/P or (uncomplexed, DNA-
free) PAMAMs solutions prepared at the same polymer
concentration used to complex pDNA were added. Plates were
next incubated at 37 °C for 24 h. Bacteria inoculated in 50 μL/
well of LB were used as positive controls (CTRL+) for bacterial
growth. The antibacterial efficacy of every compound was
evaluated by means of the turbidity method (i.e., OD600nm
measurements).36,61,62 Briefly, 24 h post inoculum, the
OD600nm of each well (n = 3 per compound) was read by
means of a GENios Plus reader. The antibacterial efficiency
was calculated according to the following equation
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Antibacterial efficiency %
1 (OD /OD ) 100600nm,compound 600nm,CTRL
[ ]
= [ − ] ×+
Statistical Analysis. Statistical analysis was carried out by
GraphPad version 6 (GraphPad software, La Jolla, CA, USA).
All data were initially analyzed using the D’Agostino & Pearson
omnibus normality test. Comparisons among groups were
performed by the multiple t-test. Significance was retained
when p < 0.05. Data are expressed as mean ± standard
deviation (SD). Experiments were performed at least in
triplicate.
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